ARD1B Inhibitors

ARD1B inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the enzyme ARD1B (N-Alpha-Acetyltransferase 10, Nat10 subunit). ARD1B is a subunit of the N-terminal acetyltransferase complex, which is responsible for catalyzing the acetylation of proteins at their N-terminal residues. This modification plays a key role in protein stability, localization, and interactions within the cell. ARD1B's enzymatic activity contributes to essential cellular processes such as protein turnover, signal transduction, and various metabolic pathways. By selectively inhibiting ARD1B, compounds within this chemical class interfere with its role in these regulatory mechanisms, leading to changes in the acetylation patterns of substrate proteins.

Inhibitors of ARD1B are valuable research tools for studying the function of N-terminal acetylation and its impact on cellular homeostasis. These compounds provide insight into how acetylation regulates diverse cellular functions, including the folding, stability, and transport of proteins. The inhibition of ARD1B can alter the expression and function of proteins involved in various intracellular pathways, allowing researchers to investigate the broader consequences of disrupted acetylation. This chemical class also aids in the study of protein-protein interactions and the identification of other acetyltransferases that may share overlapping substrates with ARD1B. Through the exploration of ARD1B inhibitors, scientists can deepen their understanding of the fundamental processes governing protein modification and regulation in biological systems.